CARLSBAD, Calif. , Aug. 28, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS ) today announced that management will participate in fireside chats at the following investor conferences: 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 Morgan Stanley 22 nd Annual Global Healthcare Conference on Thursday, September 5, 2024 A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events .
A replay will be available on the Ionis website within 48 hours and will be archived for a limited time. About Ionis Pharmaceuticals For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need.
As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.
com and follow us on X (Twitter) and LinkedIn . Ionis Pharmaceuticals Investor Contact: D. Wade Walke , Ph.
D. – [email protected] – 760-603-2331 Ionis Pharmaceuticals Media Contact: Hayley Soffer – [email protected] – 760-603-4679 SOURCE Ionis Pharmaceuticals, Inc..
